this articles about MabVax Therapeutics make two licensing agreements with the Sloan-Kettering Institute for Cancer Research. they responsibility to make a research to find a vaccine for the cancer diseases. actually, in phase 1 trial, they successful demonstration of immunogenicity and tolerability in sarcoma and small cell lung cancer. after that, they planning to find the vaccine for ovarian and breast cancer.
for more information, visit http://www.genengnews.com/news/bnitem.aspx?name=40307152&nc=1
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment